Tecnicas Reunidas (TRE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Launched the SALTA strategy to double operating margins to 8% by 2028 and reach €5 billion turnover, focusing on de-risked, digitalized EPC, expanding service contracts, and strategic alliances, notably with Sinopec.
Backlog reached €10.96 billion, up 19% year-over-year, with €1.4 billion in new orders, including major US petrochemical and Saudi Aramco projects.
H1 2024 sales totaled €2.1 billion, down 4% year-over-year, but Q2 sales rose 9% sequentially to €1.1 billion.
EBIT for H1 2024 was €84.2 million (4.0% margin), up 9% year-over-year; net profit reached €42 million.
Net cash position at June 2024 was €318 million, up from €241 million a year earlier, with gross debt reduced by €63 million in H1.
Financial highlights
H1 2024 net revenues: €2,094 million (down 4% year-over-year); Q2 2024 sales: €1,091 million (up 9% sequentially).
EBIT: €84.2 million (4.0% margin), up 9% year-over-year; EBITDA: €99.2 million, up 10% year-over-year.
Net profit: €42.1 million (2.0% margin), up 9% year-over-year.
Order intake for H1 reached €1.4 billion.
No dividends declared or paid in H1 2024 due to SEPI loan conditions.
Outlook and guidance
2024 guidance targets €4.5 billion in sales and a 4% EBIT margin, with a focus on quality backlog and selective project approach.
The SALTA plan aims for EBIT of €380 million and sales of €5 billion by 2028, with an 8% EBIT margin target.
Shareholder remuneration policy to resume, targeting at least 30% payout in 2026.
Latest events from Tecnicas Reunidas
- Record sales, strong backlog, and major contract wins support robust 2026 outlook.TRE
Q2 2026 - Sales up 21% to €1,583M; strong cash and pipeline despite €45M Middle East provision.TRE
Q1 2026 - 2025 sales rose 45% and net profit 75%, with strong backlog, transformation, and 2026 growth outlook.TRE
Q4 2025 - 9M 2025 sales up 43%, EBIT up 56%, and backlog at €11.5B with upgraded guidance.TRE
Q3 2025 - Decarbonization, digitalization, and global expansion drive ambitious revenue growth targets.TRE
Investor Day 2025 Presentation - Record sales, EBIT, and backlog in H1 2025 drive strong outlook and margin expansion.TRE
Q2 2025 - Record backlog and robust order intake fuel 58% net profit growth and margin expansion.TRE
Q3 2024 - Record backlog and major contract wins drive strong sales, profit, and 2025 outlook.TRE
Q1 2025 - Record 2024 growth and backlog support higher sales, margins, and dividend resumption by 2026.TRE
Q4 2024